Aarkstore Enterprise || Hepatic (Liver) Tumor – Pipeline Review, H2 2012

1. Hepatic (Liver) Tumor – Pipeline Review, H2 2012
Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Hepatic (Liver) Tumor – Pipeline Review, H2 2012
http://www.aarkstore.com/reports/Hepatic-Liver-Tumor-Pipeline-Review-
H2-2012-220619.html
RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml
Summary
Global Markets Direct’s, Hepatic (Liver) Tumor - Pipeline Review, H2 2012, provides
an overview of the Hepatic (Liver) Tumor therapeutic pipeline. This report provides
information on the therapeutic development for Hepatic (Liver) Tumor, complete
with latest updates, and special features on late-stage and discontinued projects. It
also reviews key players involved in the therapeutic development for Hepatic
(Liver) Tumor. Hepatic (Liver) Tumor - Pipeline Review, H2 2012 is built using data
and information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Hepatic (Liver) Tumor.
- A review of the Hepatic (Liver) Tumor products under development by companies
and universities/research institutes based on information derived from company
and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.

2. Hepatic (Liver) Tumor – Pipeline Review, H2 2012
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Hepatic (Liver) Tumor Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Hepatic (Liver) Tumor 8
Hepatic (Liver) Tumor Therapeutics under Development by Companies 10
Hepatic (Liver) Tumor Therapeutics under Investigation by Universities/Institutes
11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14
Hepatic (Liver) Tumor Therapeutics – Products under Development by Companies
15
Hepatic (Liver) Tumor Therapeutics – Products under Investigation by
Universities/Institutes 16
Companies Involved in Hepatic (Liver) Tumor Therapeutics Development 17
OXiGENE, Inc. 17
Transgene SA 18
Synta Pharmaceuticals Corp. 19
Onconova Therapeutics, Inc 20
Hepatic (Liver) Tumor – Therapeutics Assessment 21
Assessment by Monotherapy Products 21
List of Figures
List of Tables are also include.

3. Hepatic (Liver) Tumor – Pipeline Review, H2 2012
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Hepatic (Liver) Tumor – Pipeline Review, H2 2012
Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2012
Ureter Cancer – Pipeline Review, H2 2012
Acute Lymphoblastic Lymphoma – Pipeline Review, H2 2012
Fallopian Tube Cancer – Pipeline Review, H2 2012
Low-Grade Astrocytoma – Pipeline Review, H2 2012
Endometrial Cancer – Pipeline Review, H2 2012
Gastrointestinal Stromal Tumor (GIST) – Pipeline Review, H2 2012
Stroke – Pipeline Review, H2 2012
Peritoneal Cancer – Pipeline Review, H2 2012
Search More Reports Related to This Category :

4. Hepatic (Liver) Tumor – Pipeline Review, H2 2012
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com